Rabbit Polyclonal MICB antibody. Suitable for IHC-P and reacts with Human samples. Cited in 5 publications. Immunogen corresponding to Synthetic Peptide within Human MICB conjugated to Keyhole Limpet Haemocyanin.
View Alternative Names
PERB11.2, MICB, MHC class I polypeptide-related sequence B, MIC-B, PERB11.1, MICA, MHC class I polypeptide-related sequence A, MIC-A
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MICA + MICB antibody (AB203679)
Immunohistochemical analysis of formalin-fixed paraffin-embedded Human lung carcinoma tissue labeling MICA + MICB with ab203679 at 1/200 dilution, followed by conjugation to the secondary antibody and DAB staining.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MICA and MICB act in the activation of the immune system by modulating NK cells and CD8+ T cell activities. These proteins do not form part of a complex but operate independently to signal the presence of infected or transformed cells to the immune system. They often appear on the cell surface under stress such as during viral infections or cancerous transformations activating immune cells to target and destroy these abnormal cells.
Pathways
The MICA/MICB interaction with NKG2D is integral to the immune checkpoint pathway. This pathway plays a significant role in regulating the immune system’s response to aberrant cells. Additionally MICA and MICB activity is linked to the regulation of the cytokine IFN-γ promoting the recruitment and activation of immune effector cells. The roles of these proteins in these pathways underline their importance in maintaining immune homeostasis and responding to pathological challenges.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Cancer research communications 5:476-495 PubMed40116579
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2202519 PubMed36683155
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical and translational hepatology 11:614-625 PubMed36969901
2023
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 5:1233 PubMed36371589
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34502547
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com